We're not going to pursue Covid-19 at this time. I get that. Here's what I don't get; how do they (FDA) reconcile that leromlimab can save 23 per cent of the severe population after two weeks of treatment and not give it an EUA? (A rhetorical question) Let's see, according to my math, we could have saved about 275,000 lives. I'd like to know how many lives remdesivir has saved.

I've heard reports that 83 per cent of those treated with remdesivir die.